Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lithium carbonate in amyotrophic lateral sclerosis
2008-006224-61Phase 4Terminated
- Sponsor
- Hospital de la Santa Creu i Sant Pau Research Institute
- Start
- May 2009
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in amyotrophic lateral sclerosis (ALS) comparing Lithium carbonate + usual care with Placebo + usual care (2 arms). Primary endpoints: Treatment failure and Survival. Started May 2009; status: terminated.
02
Drugs
lithium carbonate
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on 2008-006224-61.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006224-61.